154 related articles for article (PubMed ID: 32979634)
1. The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients.
Ismail RK; Schramel FMNH; van Dartel M; Hilarius DL; de Boer A; Wouters MWJM; Smit HJM;
Lung Cancer; 2020 Nov; 149():68-77. PubMed ID: 32979634
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment.
Beck N; Hoeijmakers F; Wiegman EM; Smit HJM; Schramel FM; Steup WH; Verhagen AFTM; Schreurs WH; Wouters MWJM
J Thorac Dis; 2018 Oct; 10(Suppl 29):S3472-S3485. PubMed ID: 30510782
[TBL] [Abstract][Full Text] [Related]
3. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J
Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596
[TBL] [Abstract][Full Text] [Related]
4. A nationwide population-based cohort study of surgical care for patients with superior sulcus tumors: Results from the Dutch Lung Cancer Audit for Surgery (DLCA-S).
Winkelman JA; van der Woude L; Heineman DJ; Bahce I; Damhuis RA; Mahtab EAF; Hartemink KJ; Senan S; Maat APWM; Braun J; Paul MA; Dahele M; Dickhoff C
Lung Cancer; 2021 Nov; 161():42-48. PubMed ID: 34509720
[TBL] [Abstract][Full Text] [Related]
5. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.
van de Ven M; Retèl VP; Koffijberg H; van Harten WH; IJzerman MJ
Lung Cancer; 2019 Aug; 134():34-41. PubMed ID: 31319992
[TBL] [Abstract][Full Text] [Related]
6. National quality registries: how to improve the quality of data?
Hoeijmakers F; Beck N; Wouters MWJM; Prins HA; Steup WH
J Thorac Dis; 2018 Oct; 10(Suppl 29):S3490-S3499. PubMed ID: 30510784
[TBL] [Abstract][Full Text] [Related]
7. The Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia.
Mileshkin L; Dunn C; Cross H; Duffy M; Shaw M; Antippa P; Mitchell P; Akhurst T; Conron M; Moore M; Philip J; Bartlett J; Emery J; Zambello B
Intern Med J; 2019 Aug; 49(8):1001-1006. PubMed ID: 30515932
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of pulmonary metastases in the Netherlands: data from the Dutch Lung Cancer Audit for Surgery.
van Dorp M; Beck N; Steup WH; Schreurs WH
Eur J Cardiothorac Surg; 2020 Oct; 58(4):768-774. PubMed ID: 32282876
[TBL] [Abstract][Full Text] [Related]
9. Clinical auditing as an instrument to improve care for patients with ovarian cancer: The Dutch Gynecological Oncology Audit (DGOA).
Baldewpersad Tewarie NMS; van Driel WJ; van Ham M; Wouters MW; Kruitwagen R;
Eur J Surg Oncol; 2021 Jul; 47(7):1691-1697. PubMed ID: 33581966
[TBL] [Abstract][Full Text] [Related]
10. Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry.
Smit HJM; Aerts J; van den Heuvel M; Hiltermann TJN; Bahce I; Smit EF; Dingemans AC; Hendriks LE; Stigt JA; Schramel FMNH; van Tinteren H; Groen HJM;
Lung Cancer; 2020 Feb; 140():107-112. PubMed ID: 31911323
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological and therapeutic profiles of lung cancer patients in the Hokushin Region Japan: a retrospective hospital administrative database study.
Kobayashi T; Nishino Y; Takiguchi T; Kanda S; Otsuki K; Tanaka Y; Nakazawa Y; Ito KI; Hayashi R; Yasumoto K; Uramoto H; Hirono Y; Makino T; Nakada M; Yano S; Koizumi T
BMC Pulm Med; 2023 Sep; 23(1):322. PubMed ID: 37658334
[TBL] [Abstract][Full Text] [Related]
12. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
13. Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium.
Walraven I; Damhuis RA; Ten Berge MG; Rosskamp M; van Eycken L; de Ruysscher D; Belderbos JSA
Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):e177-e185. PubMed ID: 28780009
[TBL] [Abstract][Full Text] [Related]
14. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
[TBL] [Abstract][Full Text] [Related]
15. Costs of non-small cell lung cancer in the Netherlands.
van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA
Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654
[TBL] [Abstract][Full Text] [Related]
16. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
[TBL] [Abstract][Full Text] [Related]
17. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
18. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
van der Linden N; Bongers ML; Coupé VMH; Smit EF; Groen HJM; Welling A; Schramel FMNH; Uyl-de Groot CA
Clin Lung Cancer; 2017 Sep; 18(5):e341-e347. PubMed ID: 28347579
[TBL] [Abstract][Full Text] [Related]
19. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
20. The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA).
Heineman DJ; Beck N; Wouters MW; van Brakel TJ; Daniels JM; Schreurs WH; Dickhoff C
Eur J Surg Oncol; 2018 Jun; 44(6):830-834. PubMed ID: 29396329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
